Risk-Benefit Comparisons Between Shorter and Longer Durations of Adjuvant Chemotherapy in High-Risk Stage II Colorectal Cancer-Reply.
JAMA Oncol
; 6(8): 1302-1303, 2020 08 01.
Article
in English
| MEDLINE | ID: covidwho-1044841
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Colorectal Neoplasms
Type of study:
Prognostic study
Limits:
Humans
Language:
English
Journal:
JAMA Oncol
Year:
2020
Document Type:
Article
Affiliation country:
Jamaoncol.2020.2262
Similar
MEDLINE
...
LILACS
LIS